Archive: 22/04/2014

Pre-HPV vaccine, most oropharyngeal cancers HPV+

(HealthDay)—Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus (HPV), specifically HPV 16 or 18, according to a study published in the May issue of the ...

Apr 22, 2014
popularity0 comments 0

Amgen misses 1Q views as higher costs cut profit

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed Wall Street's ...

Apr 22, 2014
popularity0 comments 0